Brain Health Support Program (CTU: BHSP)
Dementia Prevention, Mild Cognitive Impairment, Subjective Cognitive Impairment
About this trial
This is an interventional prevention trial for Dementia Prevention
Eligibility Criteria
Inclusion Criteria:
- Completion and documentation of the electronic Informed Consent Process (from the participant)
- Sufficient proficiency in English or French to undergo remote clinical and neuropsychological assessment and participate in an online educational program.
- Technical ability to participate in an online educational program and remote assessments (i.e. computer and internet access; ability to send and receive emails; ability to complete remote assessments)
- Sufficient vision and hearing to participate in online educational program and to undergo remote clinical and neuropsychological testing
- Ability to sit comfortably for a period of about 30 minutes
- Ages 60-85
Meets criteria for No Dementia and meet criteria (according to CCNA Criteria, Appendix 1) of one of the following:
- Cognitively Unimpaired (CU)
- Cognitively Unimpaired plus Subjective Cognitive Impairment (CU + SCI)
- Mild Cognitive Impairment (MCI)
AND Classified as being at increased risk of dementia based on at least one of the following:
- First-degree family history of dementia
- Self-Reported or documented current and/or history at midlife (45-60 years) on any of the following lifestyle risk factors:
Hypertension (documented Systolic Blood Pressure > 140 mm Hg; OR physician diagnosis of hypertension; OR treatment for hypertension; OR other approaches to treatment (e.g. diet, exercise)) Hypercholesterolemia (documented total cholesterol > 6.5 mmol/L; OR physician diagnosis of hypercholesterolemia; OR treatment for hypercholesterolemia; OR other approaches to treatment (e.g. diet, exercise) Body Mass Index > 30 kg/m2 (derived from NIH Metric BMI Calculator) Physical Inactivity (active is defined as engaging in a minimum of 20- 30 min of physical activity causing sweating and breathlessness, at least 2 times a week)
- Participant has a family physician or other healthcare provider and agrees to have the provider notified of participation in the study and incidental or other findings that may be clinically significant
Exclusion Criteria:
- Participants who, in the opinion of the investigator, are not able to complete trial procedures remotely or adhere to the schedule of study assessments will be excluded from study participation.
- Individuals where English or French is not sufficiently proficient for remote clinical assessment, neuropsychological testing and participation in an online educational program.
- Participants who do not have sufficient vision and hearing for remote clinical assessment, neuropsychological testing participation in an online educational program
- Individuals who do not have the technical ability to participate in an online educational program. Technical ability is defined as having computer and internet access; ability to send and receive emails; ability to participate in remote assessments
- Individuals who have a clinical diagnosis of Dementia
- Clinical Dementia Rating (CDR; telephone/video-conference administration) Score of >1
- Total Score on the Montreal Cognitive Assessment (MoCA; video-conference administration) <13
Sites / Locations
- University of British Columbia
- University of New Brunswick
- Cape Breton University
- Cognitive Clinical Research Group, Parkwood Research Institute
- Gait and Brain Laboratory, Parkwood Research Institute
- Baycrest
- CRIUGM/ CIUSSS du Centre-Sud-de-l'Île-de-Montréal
Arms of the Study
Arm 1
Other
Brain Health PRO